JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status-Reference-Cited by-同舟云学术

JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status

Published:2006-09 Issue:3 Volume:77 Page:210-216
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Heller Paula G.,Lev Paola R.,Salim Juan P.,Kornblihtt Laura I.,Goette Nora P.,Chazarreta Carlos D.,Glembotsky Ana C.,Vassallu Patricia S.,Marta Rosana F.,Molinas Felisa C.

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2006.00688.x/fullpdf

Reference23 articles.

1. Essential Thrombocythemia

2. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell

3. A Large Proportion of Patients With a Diagnosis of Essential Thrombocythemia Do Not Have a Clonal Disorder and May Be at Lower Risk of Thrombotic Complications

4. Clonality Analysis of Hematopoiesis in Essential Thrombocythemia: Advantages of Studying T Lymphocytes and Platelets

5. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology;Diagnostics;2023-01-03

2. Molecular genetics of thrombotic myeloproliferative neoplasms: Implications in precision oncology;Genes & Diseases;2021-01

3. Relationship between JAK2-V617F mutation and hematologic parameters in Philadelphia-negative chronic myeloproliferative neoplasms;Turkish Journal of Biochemistry;2020-11-02

4. Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms;Frontiers in Immunology;2019-06-14

5. Essential thrombocythemia during treatment of acute myeloid leukemia with JAK2 V617F mutation;Medicine;2018-07